3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Gastrointestinal Stromal Tumors
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Melanoma
2
Leukemia
2
Burkitt Lymphoma
2
Uveal Melanoma
1
Squamous Cell Carcinoma of Head and Neck
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Neoplasm, Residual
1
Myeloproliferative Disorders
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid
1
Leukemia, Biphenotypic, Acute
1
Hypereosinophilic Syndrome
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
Digestive System Neoplasms
1
Desmoid Tumors
1
Dermatofibrosarcoma
1
Congenital Bone Marrow Failure Syndromes
1
Chordoma
1
Carcinoma, Adenoid Cystic
1
Blast Crisis
1
Interventions
Specimen Handling
3
Radiotherapy
3
Radiation
3
Doxorubicin
3
Biopsy
3
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Gemcitabine
2
toripalimab
1
talimogene laherparepvec
1
ribociclib
1
peposertib
1
pazopanib
1
liposomal doxorubicin
1
cabozantinib
1
abemaciclib
1
Temozolomide
1
Surgical Procedures, Operative
1
PM 01183
1
Neoadjuvant Therapy
1
Ifosfamide
1
Everolimus
1
Docetaxel
1
BO-112
1
ADI PEG20
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leiomyosarcoma
×
Imatinib Mesylate
×
90 days
×
Clear all
No trials found.